Related references
Note: Only part of the references are listed.Variable and fixed costs in NHS radiotherapy; consequences for increasing hypo fractionation
Katie Spencer et al.
RADIOTHERAPY AND ONCOLOGY (2022)
Survey of brachytherapy training experience among radiation oncology trainees and fellows in the Royal Australian and New Zealand College of Radiologists (RANZCR)
Wee Loon Ong et al.
JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY (2022)
Cancer in sub-Saharan Africa: a Lancet Oncology Commission
Wilfred Ngwa et al.
LANCET ONCOLOGY (2022)
Lessons from the Brazilian radiotherapy expansion plan: A project database study
Samir Abdallah Hanna et al.
LANCET REGIONAL HEALTH-AMERICAS (2022)
Randomised trial of external-beam radiotherapy alone or with high-dose-rate brachytherapy for prostate cancer: Mature 12-year results
Peter J. Hoskin et al.
RADIOTHERAPY AND ONCOLOGY (2021)
Short Androgen Suppression and Radiation Dose Escalation in Prostate Cancer: 12-Year Results of EORTC Trial 22991 in Patients With Localized Intermediate-Risk Disease
Michel Bolla et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Examining the Financial Impact of Altered Fractionation in Breast Cancer: An Analysis Using Time-Driven Activity-Based Costing
Mark Dziemianowicz et al.
PRACTICAL RADIATION ONCOLOGY (2021)
Palliative radiotherapy after oesophageal cancer stenting (ROCS): a multicentre, open-label, phase 3 randomised controlled trial
Douglas Adamson et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2021)
Utilization of brachytherapy in Quebec, Canada
Magali Lecavalier-Barsoum et al.
BRACHYTHERAPY (2021)
Brachytherapy utilization rate and effect on survival in cervical cancer patients in Korea
Young Ae Kim et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2021)
National Healthcare Economic Evaluation Guidelines: A Cross-Country Comparison
Deepshikha Sharma et al.
PHARMACOECONOMICS-OPEN (2021)
How public health services pay for radiotherapy in Europe: an ESTRO-HERO analysis of reimbursement
Yolande Lievens et al.
LANCET ONCOLOGY (2020)
The Cost-Effectiveness and Value Proposition of Brachytherapy
Charles C. Vu et al.
SEMINARS IN RADIATION ONCOLOGY (2020)
Brachytherapy in Belgium in 2018. A national survey of the brachytherapy study group of the Belgian SocieTy for Radiotherapy and Oncology (BeSTRO)
Carl Salembier et al.
RADIOTHERAPY AND ONCOLOGY (2020)
Planned organ preservation for early T2-3 rectal adenocarcinoma: A French, multicentre study
Jean-Pierre Gerard et al.
EUROPEAN JOURNAL OF CANCER (2019)
Scale-up of radiotherapy for cervical cancer in the era of human papillomavirus vaccination in low-income and middle-income countries: a model-based analysis of need and economic impact
Danielle Rodin et al.
LANCET ONCOLOGY (2019)
National costs and resource requirements of external beam radiotherapy: A time-driven activity-based costing model from the ESTRO-HERO project
Noemie Defourny et al.
RADIOTHERAPY AND ONCOLOGY (2019)
Brachytherapy: A critical component of primary radiation therapy for cervical cancer: From the Society of Gynecologic Oncology (SGO) and the American Brachytherapy Society (ABS)
Christine H. Holschneider et al.
BRACHYTHERAPY (2019)
A Cost-Effectiveness Analysis of Contact X-ray Brachytherapy for the Treatment of Patients with Rectal Cancer Following a Partial Response to Chemoradiotherapy
C. Rao et al.
CLINICAL ONCOLOGY (2018)
Objectives, Budgets, Thresholds, and Opportunity Costs-A Health Economics Approach: An ISPOR Special Task Force Report [4]
Patricia M. Danzon et al.
VALUE IN HEALTH (2018)
Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy
B. G. Wortman et al.
BRITISH JOURNAL OF CANCER (2018)
A systematic review of treating recurrent head and neck cancer: a reintroduction of brachytherapy with or without surgery
Julianna Rodin et al.
JOURNAL OF CONTEMPORARY BRACHYTHERAPY (2018)
Cost in perspective: direct assessment of American market acceptability of Co-60 in gynecologic high-dose-rate brachytherapy and contrast with experience abroad
Raymond B. Mailhot Vega et al.
JOURNAL OF CONTEMPORARY BRACHYTHERAPY (2018)
Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer
W. James Morris et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Optimal utilisation of brachytherapy in Europe -can it be measured?
J. M. Borras
RADIOTHERAPY AND ONCOLOGY (2017)
High-dose-rate interstitial brachytherapy in head and neck cancer: do we need a look back into a forgotten art - a single institute experience
Rajendra Bhalavat et al.
JOURNAL OF CONTEMPORARY BRACHYTHERAPY (2017)
Health economics of targeted intraoperative radiotherapy (TARGIT-IORT) for early breast cancer: a cost-effectiveness analysis in the United Kingdom
Anil Vaidya et al.
BMJ OPEN (2017)
Brachytherapy boost for prostate cancer: Trends in care and survival outcomes
S. M. Glaser et al.
BRACHYTHERAPY (2017)
Who Should Bear the Cost of Convenience? A Cost-effectiveness Analysis Comparing External Beam and Brachytherapy Radiotherapy Techniques for Early Stage Breast
M. McGuffin et al.
CLINICAL ONCOLOGY (2017)
Brachytherapy: a dying art or missed opportunity?
Annette Haworth
AUSTRALASIAN PHYSICAL & ENGINEERING SCIENCES IN MEDICINE (2016)
Economic evaluation of treatments for patients with localized prostate cancer in Europe: a systematic review
Virginia Becerra et al.
BMC HEALTH SERVICES RESEARCH (2016)
Time-driven activity-based costing of low-dose-rate and high-dose-rate brachytherapy for low-risk prostate cancer
Annette M. Ilg et al.
BRACHYTHERAPY (2016)
The decreased use of brachytherapy boost for intermediate and high-risk prostate cancer despite evidence supporting its effectiveness
Peter F. Orio et al.
BRACHYTHERAPY (2016)
Disparities in standard of care treatment and associated survival decrement in patients with locally advanced cervical cancer
Tyler P. Robin et al.
GYNECOLOGIC ONCOLOGY (2016)
Short Androgen Suppression and Radiation Dose Escalation for Intermediate- and High-Risk Localized Prostate Cancer: Results of EORTC Trial 22991
Michel Bolla et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Estimation of the optimal utilisation rates of radical prostatectomy, external beam radiotherapy and brachytherapy in the treatment of prostate cancer by a review of clinical practice guidelines
Stephen R. Thompson et al.
RADIOTHERAPY AND ONCOLOGY (2016)
Cost evaluations of radiotherapy: What do we know? An ESTRO-HERO analysis
Noemie Defourny et al.
RADIOTHERAPY AND ONCOLOGY (2016)
Time-Driven Activity-Based Costing: A Comparative Cost Analysis of Whole-Breast Radiotherapy Versus Balloon-Based Brachytherapy in the Management of Early-Stage Breast Cancer
Matthew E. Schutzer et al.
JOURNAL OF ONCOLOGY PRACTICE (2016)
The Case for Prostate Brachytherapy in the Affordable Care Act Era
Ben Y. Durkee et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Postoperative Radiation Therapy for Endometrial Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Guideline
Larissa A. Meyer et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
The optimal utilization proportion of external beam radiotherapy in European countries: An ESTRO-HERO analysis
Josep M. Borras et al.
RADIOTHERAPY AND ONCOLOGY (2015)
National Cancer Data Base Analysis of Radiation Therapy Consolidation Modality for Cervical Cancer: The Impact of New Technological Advancements
Beant S. Gill et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
Brachytherapy in India - a long road ahead
Susovan Banegee et al.
JOURNAL OF CONTEMPORARY BRACHYTHERAPY (2014)
Systematic Review of the Cost Effectiveness of Radiation Therapy for Prostate Cancer from 2003 to 2013
Neha Amin et al.
APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2014)
Trends in the Utilization of Brachytherapy in Cervical Cancer in the United States
Kathy Han et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Consolidated Health Economic Evaluation Reporting Standards (CHEERS)-Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force
Don Husereau et al.
VALUE IN HEALTH (2013)
Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group
Peter Grimm et al.
BJU INTERNATIONAL (2012)
American Brachytherapy Society consensus guidelines for adjuvant vaginal cuff brachytherapy after hysterectomy
William Small et al.
BRACHYTHERAPY (2012)
American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: High-dose-rate brachytherapy
Akila N. Viswanathan et al.
BRACHYTHERAPY (2012)
American Brachytherapy Society consensus guidelines for high-dose-rate prostate brachytherapy
Yoshiya Yamada et al.
BRACHYTHERAPY (2012)
American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy
Brian J. Davis et al.
BRACHYTHERAPY (2012)
Randomised trial of external beam radiotherapy alone or combined with high-dose-rate brachytherapy boost for localised prostate cancer
Peter J. Hoskin et al.
RADIOTHERAPY AND ONCOLOGY (2012)
Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial
R. A. Nout et al.
LANCET (2010)
Brachytherapy in the United Kingdom and Spain: a subset analysis of a European pattern of care survey
Ferran Guedea et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2009)
Estimation of optimal brachytherapy utilization rate in the treatment of malignancies of the uterine corpus by a review of clinical practice guidelines and the primary evidence
Stephen R. Thompson et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Implications of learning effects for hospital costs of new health technologies:: The case of intensity modulated radiation therapy
Julia Bonastre et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2007)
Estimation of the optimal brachytherapy utilization rate in the treatment of carcinoma of the uterine cervix - Review of clinical practice guidelines and primary evidence
Stephen Thompson et al.
CANCER (2006)
Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial
MYV Homs et al.
LANCET (2004)
Share Paper
